Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...

Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...

Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...

HRV Pharma, based in Hyderabad, is set to invest ₹150 crore to enhance its peptide manufacturing capabilities and develop ...

Novo Nordisk reports a significant reduction in obesity rates among children aged 6 to under 12 treated with semaglutide in a ...

New Zealand's health authorities have granted approval for the use of MDMA in treating severe PTSD, making it only the second ...

Novartis India has announced the acquisition of Pfizer's hypertension drug Minipress for ₹1250 crore, aiming to enhance its ...

New Delhi: More than 60% of the 8,500 registered small and medium pharmaceutical units in India may be forced to shut shop by the end of this month for failing to comply with the guidelines on good ...

Fosun Pharma reduces its stake in Gland Pharma, selling 4.5% through block deals on BSE, attracting several major investors ...

Piyush Goyal calls for regulatory alignment with developed countries to boost investment and innovation in India's ...

RPG Life Sciences plans to invest Rs 500 crore over the next year to enhance its manufacturing and Active Pharmaceutical ...

The European Medicines Agency reviews injectable iron medicines due to concerns about low phosphate levels and potential bone ...